Estrous Cycle-Dependent Phasic Changes in the Stoichiometry of Hippocampal Synaptic AMPA Receptors in Rats

PLoS One. 2015 Jun 29;10(6):e0131359. doi: 10.1371/journal.pone.0131359. eCollection 2015.

Abstract

Cognitive function can be affected by the estrous cycle. However, the effect of the estrous cycle on synaptic functions is poorly understood. Here we show that in female rats, inhibitory-avoidance (IA) task (hippocampus-dependent contextual fear-learning task) drives GluA2-lacking Ca2+-permeable AMPA receptors (CP-AMPARs) into the hippocampal CA3-CA1 synapses during all periods of the estrous cycle except the proestrous period, when estrogen levels are high. In addition, IA task failed to drive CP-AMPARs into the CA3-CA1 synapses of ovariectomized rats only when estrogen was present. Thus, changes in the stoichiometry of AMPA receptors during learning depend on estrogen levels. Furthermore, the induction of long-term potentiation (LTP) after IA task was prevented during the proestrous period, while intact LTP is still expressed after IA task during other period of the estrous cycle. Consistent with this finding, rats conditioned by IA training failed to acquire hippocampus-dependent Y-maze task during the proestrous period. On the other hand, during other estrous period, rats were able to learn Y-maze task after IA conditioning. These results suggest that high estrogen levels prevent the IA learning-induced delivery of CP-AMPARs into hippocampal CA3-CA1 synapses and limit synaptic plasticity after IA task, thus preventing the acquisition of additional learning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Avoidance Learning / drug effects
  • CA3 Region, Hippocampal / drug effects
  • CA3 Region, Hippocampal / metabolism
  • Calcium / metabolism
  • Cell Membrane Permeability / drug effects
  • Dendritic Spines / drug effects
  • Dendritic Spines / metabolism
  • Estrogens / pharmacology
  • Estrous Cycle* / drug effects
  • Female
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Long-Term Potentiation / drug effects
  • Neural Inhibition / drug effects
  • Ovariectomy
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / metabolism
  • Rats, Wistar
  • Receptors, AMPA / metabolism*
  • Synapses / drug effects
  • Synapses / metabolism*
  • Task Performance and Analysis

Substances

  • Estrogens
  • Receptors, AMPA
  • Calcium

Grants and funding

This research was funded in part by The Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/Minds) (14029040), Special Coordination Funds for Promoting Science and Technology (11800122), the Strategic Research Program for Brain Sciences (09150699), KAKENHI (23590286, 24700382).